腫瘍抑制剤PP2Aアベータは,RalA GTPアゼを調節する
Anna A Sablina1, Wen Chen, Jason D Arroyo
1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
Cell
|June 2, 2007
まとめ
タンパク質フォスファタゼ2A (PP2A) アベタ亜単位は,腫瘍抑制剤として作用する. PP2A Abetaの癌に関連した変異は,RalAの不活性化を防ぐことで,その腫瘍抑制機能を無効化する.
科学分野:
- 分子生物学は分子生物学である.
- 腫瘍学 腫瘍学
- 細胞生物学 細胞生物学
背景:
- セリン・スレオニンタンパク質フォスファタゼ2A (PP2A) は,細胞信号伝達経路を調節する重要な酵素ファミリーです.
- PP2A Abetaサブユニットのバイアレル変異は,様々なヒト腫瘍で観察されていますが,細胞変異に対する機能的な影響は不明です.
研究 の 目的:
- 癌に関連したPP2Aアベタ変異の機能的影響を細胞変異で調査する.
- 小型GTPase RalAの調節におけるPP2Aアベタの役割を決定する.
主な方法:
- 不死のヒト細胞におけるPP2Aアベタの遺伝子発現抑制.
- 細胞変容と腫瘍発生現象型の分析.
- PP2A アベタとRALAの間のタンパク質複合体の形成を評価するための共免疫プレシピテーション.
- In vitroフォスファタゼアッセイでは,RalAのリン酸化状態を決定する.
主要な成果:
- PP2Aアベタ発現の抑制は,不死のヒト細胞で腫瘍発生状態を誘発した.
- 癌に関連したPP2Aアベタ変異体は,ヌルアルレルとして機能し,腫瘍発生性フェノタイプを逆転させなかった.
- 野生型のPP2Aアベータは癌変異体ではないが,RalA.と複合体を形成した.
- PP2A アベタ複合体は,特定の部位でRalAを脱リン化し,その無活性化につながります.
結論:
- PP2Aアベータは腫瘍抑制遺伝子として機能する.
- PP2A Abetaは,小さなGTPase RalA.を不活性化することによって,細胞変異を調節する.
- PP2A Abetaの癌に関連した変異は,RalAの調節を損なうことで,その腫瘍抑制活動を妨害する.
関連する概念動画
01:23Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
01:14Rab Proteins
Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
02:38The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
01:24Small GTPases - Ras and Rho
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...